Clinical Trial Enzyme Application Targeting Venous Leg Ulcers

Completed · Phase 2

Conditions studied: Venous Leg Ulcer, Leg Injuries and Disorders

In brief

This is an adaptive open-label, first-in-human (Phase IIa) study designed to assess the safety (and efficacy) of Aurase Wound Gel, an enzymatic debridement product, intended for topical application to sloughy venous leg ulcers (VLU)

Key facts

Study ID
NCT04956900
Run by
SolasCure Limited
People needed
43
Starts
2021-08-09
Expected to finish
2023-02-06
Last updated by the study team
2023-02-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.